Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain metastases.

Kevin J Klos1, Brian Patrick O'Neill

  • 1Department of Mayo Clinic, Rochester, MN, USA. klos.kevin@mayo.edu

The Neurologist
|January 15, 2004
PubMed
Summary
This summary is machine-generated.

Brain metastases, a complication of systemic cancer, present diagnostic and treatment challenges. Understanding pathophysiology and advances improve patient quality of life and life expectancy, though further studies are needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic Experience.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2020
Same author

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Neurology. Clinical practice·2017
Same author

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

The New England journal of medicine·2015
Same author

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2015
Same author

Second malignancies in patients with primary central nervous system lymphoma.

Neuro-oncology·2014
Same author

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.

Nature genetics·2014
Same journal

Looking Beyond the Midline: An Uncommon Etiology of Internuclear Ophthalmoplegia of Abduction Due to Cerebral Venous Thrombosis.

The neurologist·2026
Same journal

Commentary: Cervical Artery Dissection and Chiropractic Cervical Manipulation: Clarifying Association, Mechanism, and Interpretation.

The neurologist·2026
Same journal

Acute Spinal Cord Infarct Secondary to Fibrocartilaginous Embolism Treated With Tenecteplase.

The neurologist·2026
Same journal

Cervical Artery Dissection and Chiropractic​​​​​.

The neurologist·2026
Same journal

Oromandibular Dyskinesia Associated With Levofloxacin and Responsive to Low-Dose Oral Diazepam: A Case Report.

The neurologist·2026
Same journal

Spinal H-Sign in Syphilitic Myelitis Mimicking MOGAD.

The neurologist·2026
See all related articles

Area of Science:

  • Neuro-oncology
  • Medical oncology
  • Neurology

Background:

  • Systemic cancer is a leading cause of death, with 20% of patients developing neurologic symptoms.
  • Brain metastases are an increasing challenge for healthcare providers, causing significant morbidity and mortality.
  • Understanding the diagnosis and treatment of brain metastases is crucial.

Purpose of the Study:

  • To review the epidemiology, clinical features, pathophysiology, and diagnostic evaluation of brain metastases.
  • To summarize current treatment approaches based on primary tumor location and other metastatic tumors.
  • To highlight treatment controversies and novel approaches under investigation.

Main Methods:

  • Comprehensive literature evaluation.
  • Analysis of treatment strategies for common primary tumor locations.

Related Experiment Videos

  • Discussion of ongoing research and clinical studies.

    • Main Results:

    • Advances in understanding pathophysiology and diagnostic technology enhance treatment approaches for brain metastases.
    • Current therapies can improve patient quality of life and life expectancy.
    • Tailoring treatment based on primary cancer type improves effectiveness.

    Conclusions:

    • Improved understanding of brain metastases pathophysiology and diagnostics leads to better treatment.
    • While no cure exists, available therapies significantly enhance patient outcomes.
    • Further research is essential to validate treatment benefits in specific patient populations.